MRC Clinical Trials Unit at UCL
Menu
Home
About
Our Structure
Our People
'25 at 25' series
Our Environmental Commitment
News
Research
Cancer
Add-Aspirin
ARCHERY
RAMPART
REFINE
STAMPEDE
STAMPEDE2
STOPCAP
UKCTOCS
PATCH
Open studies
Past Studies
Infections
Studies by Research Area
Neurodegenerative Diseases
ACORD collaboration
OCTOPUS
EJS ACT-PD
MRC Clinical Trials Unit ACORD Fellows Academy
Methodology
Design
Conduct
Analysis
Meta-analysis
Software
Other Research & Policy
Data Sharing
Publications
Studies in other areas
Briefing Papers
Regulatory information, Toolkits & Templates
Our podcast
Studies
All Studies
Studies Search
Patients & Public
About Clinical Trials
What is a clinical trial?
What is a randomised clinical trial?
What is an observational study?
How do we make sure a trial is safe?
How is a trial designed and run?
What happens at the end of a trial?
Taking Part in a Clinical Trial
How can you take part in a trial?
What questions should you ask before participating in a trial?
Patient and Public Involvement
About our PPI group
Our PPI Strategy
PPI Resources
Study & Careers
Capacity Strengthening
Enhancing skills of trial teams we work with across the globe
Improving the clinical trials ecosystem
NIHR Associate Principal Investigator (PI) Scheme
Contact
Search the site
Andrew Nunn, Emeritus Professor of Epidemiology
UCL Profile of Andrew Nunn
Research Areas
Infections
Tuberculosis
Related Studies
BLISTER
REMOX TB
RIFAQUIN
STREAM Stage 1
STREAM Stage 2
TRUNCATE-TB
Related News
'25 at 25': Shortening treatment for tuberculosis
22 Mar 2024
Home
About Us
Our People
Andrew Nunn
